These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37881393)

  • 1. Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways.
    Zakir M; Ahuja N; Surksha MA; Sachdev R; Kalariya Y; Nasir M; Kashif M; Shahzeen F; Tayyab A; Khan MSM; Junejo M; Manoj Kumar F; Varrassi G; Kumar S; Khatri M; Mohamad T
    Cureus; 2023 Sep; 15(9):e45835. PubMed ID: 37881393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does microvascular disease predict macrovascular events in type 2 diabetes?
    Rosenson RS; Fioretto P; Dodson PM
    Atherosclerosis; 2011 Sep; 218(1):13-8. PubMed ID: 21763654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.
    Babel RA; Dandekar MP
    Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study.
    Schallmoser S; Zueger T; Kraus M; Saar-Tsechansky M; Stettler C; Feuerriegel S
    J Med Internet Res; 2023 Feb; 25():e42181. PubMed ID: 36848190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus.
    Sanabria-de la Torre R; García-Fontana C; González-Salvatierra S; Andújar-Vera F; Martínez-Heredia L; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
    Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
    Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of the complications of diabetes.
    Vinik AI; Vinik E
    Am J Manag Care; 2003 Mar; 9(3 Suppl):S63-80; quiz S81-4. PubMed ID: 12653455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review.
    Taylor OM; Lam C
    Curr Ther Res Clin Exp; 2020; 93():100596. PubMed ID: 32817765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM study.
    Hayfron-Benjamin C; van den Born BJ; Maitland-van der Zee AH; Amoah AGB; Meeks KAC; Klipstein-Grobusch K; Bahendeka S; Spranger J; Danquah I; Mockenhaupt F; Beune E; Smeeth L; Agyemang C
    J Diabetes Complications; 2019 Aug; 33(8):572-578. PubMed ID: 31167710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between macrovascular and renal microvascular dysfunction in type 2 diabetes and non-diabetes: the HELIUS study.
    Hayfron-Benjamin CF; Amoah AGB; Maitland-van der Zee AH; Moll van Charante EP; Galenkamp H; van den Born BJ; Agyemang C
    Microvasc Res; 2021 Jul; 136():104162. PubMed ID: 33705823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrovascular effects and safety issues of therapies for type 2 diabetes.
    Plutzky J
    Am J Cardiol; 2011 Aug; 108(3 Suppl):25B-32B. PubMed ID: 21802578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
    Paul S; Ali A; Katare R
    J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
    Lunder M; Janić M; Šabovič M
    Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes.
    Palladino R; Tabak AG; Khunti K; Valabhji J; Majeed A; Millett C; Vamos EP
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332069
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.